Bonacorda Jeffrey — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Bonacorda Jeffrey has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Jeffrey Bonacorda is a finance executive identified in SEC filings as Vice President, Finance and Controller for Kazia Therapeutics Ltd as of the filing dated 2026-07-08. In this capacity, he would oversee financial reporting, accounting, internal controls over financial reporting, treasury and related corporate finance functions, and coordination with external auditors for Kazia Therapeutics Ltd, an Australian-listed biotechnology company focused on oncology drug development.
Role
VP, Finance and Controller
Notability
12/100
Board memberships
Kazia Therapeutics Ltd
Awards & honors
Listed as VP, Finance and Controller in SEC filing dated 2026-07-08 for Kazia Therapeutics Ltd
Responsible for financial reporting, accounting practices, and internal controls at Kazia Therapeutics Ltd
Jeffrey Bonacorda is a finance executive identified in SEC filings as Vice President, Finance and Controller for Kazia Therapeutics Ltd as of the filing dated 2026-07-08. In this capacity, he would oversee financial reporting, accounting, internal controls over financial reporting, treasury and related corporate finance functions, and coordination with external auditors for Kaz…
How many SEC Form 4 filings has Bonacorda Jeffrey submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Bonacorda Jeffrey's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
